Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.16 USD | +2.19% | +8.11% | -8.34% |
May. 31 | Exelixis Insider Bought Shares Worth $8,733,955, According to a Recent SEC Filing | MT |
May. 20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.34% | 6.32B | |
+14.05% | 118B | |
+13.48% | 106B | |
-2.57% | 24.28B | |
+0.76% | 21.96B | |
-9.26% | 18.16B | |
-42.12% | 16.37B | |
-17.30% | 15.56B | |
+5.35% | 13.63B | |
+30.62% | 12.27B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Transcript : Exelixis, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 04